相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The efficacy of bortezomib in human multiple myeloma cells is enhanced by combination with omega-3 fatty acids DHA and EPA: Timing is essential
Jing Chen et al.
CLINICAL NUTRITION (2021)
Ferroptosis: molecular mechanisms and health implications
Daolin Tang et al.
CELL RESEARCH (2021)
Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death
Melody Caillot et al.
CANCERS (2021)
Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation
Jing Chen et al.
CELLS (2021)
EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner
Esmaeil Mortaz et al.
CLINICAL NUTRITION (2020)
Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signaling
Jelle Folkerts et al.
ALLERGY (2020)
Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma
Yvette N. Lamb
DRUGS (2020)
Role of Glutathione in Cancer: From Mechanisms to Therapies
Luke Kennedy et al.
BIOMOLECULES (2020)
Relapsed refractory multiple myeloma: a comprehensive overview
Abdul Hamid Bazarbachi et al.
LEUKEMIA (2019)
Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target
Jing Chen et al.
CELLS (2019)
Drug resistance in multiple myeloma
Pawel Robak et al.
CANCER TREATMENT REVIEWS (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway
Meng-Shian Chen et al.
ONCOTARGET (2017)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
K. K. Starheim et al.
BLOOD CANCER JOURNAL (2016)
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
H. M. Lokhorst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells
J. Abdi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults
Rene A. Braeckman et al.
DRUGS IN R&D (2014)
Proteasome inhibitors in the treatment of multiple myeloma
Ali McBride et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers
Antonio Rusca et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Clinical overview of omacor: A concentrated formulation of omega-3 polyunsaturated fatty acids
Harold Bays
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Distribution, interconversion, and dose response of n-3 fatty acids in humans
Linda M. Arterburn et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib
CR Berkers et al.
NATURE METHODS (2005)